Explore

Trendline Trendline
Lifestyle Changes Post-Cancer Diagnosis May Improve Survival Rates

Lifestyle Changes Post-Cancer Diagnosis May Improve Survival Rates

Lifestyle Changes Post-Cancer Diagnosis May Improve Survival Rates
Reuters Reuters
J&J prostate cancer drug reduces risk of cancer spread and death in late-stage study

J&J prostate cancer drug reduces risk of cancer spread and death in late-stage study

By Sneha S K May 31 (Reuters) - Johnson & Johnson's prostate cancer drug Erleada used with hormone-blocking therapy six months before and after prostate surgery improved the chances of eliminating the cancer and reduced the risk of disease progression or death, according to data from a late-stage
Trendline Trendline
Americans Encouraged to Embrace Casual Socializing at Home

Americans Encouraged to Embrace Casual Socializing at Home

Americans Encouraged to Embrace Casual Socializing at Home
Trendline Trendline
Open EMDR Platform Offers Self-Guided Therapy for Mental Health Management

Open EMDR Platform Offers Self-Guided Therapy for Mental Health Management

Open EMDR Platform Offers Self-Guided Therapy for Mental Health Management
Rapid Read Rapid Read
NYU Langone Health Study Shows Cancer Vaccine Reduces Melanoma Recurrence by 49%

NYU Langone Health Study Shows Cancer Vaccine Reduces Melanoma Recurrence by 49%

A study led by NYU Langone Health and its Perlmutter Cancer Center has demonstrated that a combination of a vaccine, intismeran, and the immunotherapy drug pembrolizumab (Keytruda) can significantly reduce the risk of melanoma recurrence and death. The phase 2b trial, known as KEYNOTE-942, involved 107 patients who had undergone melanoma surgery. The results, presented at the 2026 annual meeting of the American Society of Clinical Oncology, showed that the combination therapy reduced the risk of cancer recurrence or death by 49% compared to the standard treatment of pembrolizumab alone. Additionally, the combination therapy reduced the risk of distant metastasis by 59%. The study highlights the potential of mRNA vaccines like intismeran in enhancing the effectiveness of immunotherapy for cancers with high mutation rates.
Rapid Read Rapid Read
ASCO Highlights Impact of Natural Disasters on Cancer Care

ASCO Highlights Impact of Natural Disasters on Cancer Care

At the American Society of Clinical Oncology (ASCO) 2026 session, experts discussed the compounded challenges faced by cancer care due to natural disasters, wars, and policy decisions. Dr. Manali Patel from Stanford University highlighted the lack of data connecting climate-related natural disasters to cancer outcomes, despite evidence of increased mortality rates among cancer patients exposed to such events. The session emphasized the need for proactive emergency planning in hospitals, drawing lessons from past experiences like the Texas Medical Center's response to Tropical Storm Allison. The discussion also covered the impact of geopolitical conflicts on cancer care access, particularly in war-torn regions, and the challenges faced by undocumented immigrants in the U.S. in accessing cancer treatment.
Trendline Trendline
Pfizer's BRAFTOVI Regimen Shows Promising Results in Metastatic Colorectal Cancer Treatment

Pfizer's BRAFTOVI Regimen Shows Promising Results in Metastatic Colorectal Cancer Treatment

Pfizer's BRAFTOVI Regimen Shows Promising Results in Metastatic Colorectal Cancer Treatment
Rapid Read Rapid Read
New Hormone Regimen May Improve Outcomes for Prostate Cancer Surgery Patients

New Hormone Regimen May Improve Outcomes for Prostate Cancer Surgery Patients

A recent phase 3 clinical trial, known as the PROTEUS trial, has revealed promising results for prostate cancer patients undergoing surgery. Traditionally, patients with high-risk prostate cancer that has not spread have two main treatment options: surgical removal of the prostate or a combination of radiation therapy and hormone therapy. The trial suggests a third option, combining two hormone therapies both before and after surgery, which has shown to be superior to the existing method of using just one hormone therapy. This development is being hailed by some oncologists as a potential new standard of care, with Emmanual Antonarakis, a genitourinary medical oncologist at the University of Minnesota, describing it as a 'watershed moment' in prostate cancer treatment.
Rapid Read Rapid Read
ASCO Highlights Challenges in Cancer Care Due to War, Disasters, and Policy

ASCO Highlights Challenges in Cancer Care Due to War, Disasters, and Policy

At the ASCO 2026 education session, experts discussed the compounded challenges in cancer care arising from war, natural disasters, and policy decisions. The session highlighted the plight of displaced Africans, survivors of climate-related disasters, and undocumented immigrants in the U.S. Dr. Nazik Hammad emphasized the lack of cancer care infrastructure in conflict zones, while Dr. Manali Patel pointed out the disruption of medical services due to natural disasters. Dr. Patricia Mae Garia Santos addressed the limited access to cancer care for undocumented immigrants, exacerbated by policy restrictions under the Affordable Care Act. These discussions underscored the need for global solidarity and policy advocacy to ensure equitable cancer care access.
Rapid Read Rapid Read
Research Links Poor Sleep to Increased Cancer Risk in Under-50s

Research Links Poor Sleep to Increased Cancer Risk in Under-50s

Recent studies presented at the American Society of Clinical Oncology's annual meeting in Chicago have highlighted a potential link between poor sleep patterns and an increased risk of early-onset cancers in individuals under 50. Conducted by the MD Anderson Cancer Center in Houston, the research analyzed health data from over 18 million U.S. adults aged 18 to 50. Findings suggest that those with irregular sleeping patterns are more likely to develop cancers such as bowel, breast, uterine, or ovarian cancer. In some cases, individuals diagnosed with insomnia were found to be three times more likely to develop cancer within five years. The studies underscore sleep disruption as a potentially modifiable risk factor in early-onset cancer risk stratification, warranting further investigation.
Trendline Trendline
Sleep's Role in Longevity Gains Recognition in Health Discussions

Sleep's Role in Longevity Gains Recognition in Health Discussions

Sleep's Role in Longevity Gains Recognition in Health Discussions
AP News AP News
Malaysia enforces ban on social media accounts for children younger than 16

Malaysia enforces ban on social media accounts for children younger than 16

Malaysia has begun enforcing its ban on children under 16 having social media accounts